Previous Article
The characteristics of a “winning” biotech startup
The characteristics of a “winning” biotech startup

QureTech Bio AB, a startup developing first line drugs to combat antibiotic resistance and infectious disea...

Next Article
Getting orphan drugs approved and to the patient is what drives Tim Coté, CEO of Coté Orphan
Getting orphan drugs approved and to the patient is what drives Tim Coté, CEO of Coté Orphan

Dr. Tim Coté is a no-nonsense guy. The principal and chief executive officer of Coté Orphan is as passionat...